{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T14:41:34Z","timestamp":1770993694578,"version":"3.50.1"},"reference-count":18,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2009,11,1]],"date-time":"2009-11-01T00:00:00Z","timestamp":1257033600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2009,11,1]],"date-time":"2009-11-01T00:00:00Z","timestamp":1257033600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2009,11,1]],"date-time":"2009-11-01T00:00:00Z","timestamp":1257033600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["international-journal-of-gynecological-cancer.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Gynecological Cancer"],"published-print":{"date-parts":[[2009,11]]},"DOI":"10.1111\/igc.0b013e3181a83ed9","type":"journal-article","created":{"date-parts":[[2010,12,3]],"date-time":"2010-12-03T13:48:52Z","timestamp":1291384132000},"page":"1342-1346","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":37,"title":["Overexpression of Clusterin in Ovarian Cancer is Correlated With Impaired Survival"],"prefix":"10.1016","volume":"19","author":[{"given":"Guofen F.","family":"Yang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoming M.","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dan","family":"Xie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"suppl 12","key":"10.1111\/IGC.0b013e3181a83ed9_bb0005","first-page":"40","article-title":"Cyclophosphamide and cisplatin versus paclitaxel and cisplatin: a phase III randomized trial in patients with suboptimal stage III\/IV ovarian cancer (from the Gynecologic Oncology Group)","volume":"23","author":"McGuire","year":"1996","journal-title":"Semin Oncol."},{"key":"10.1111\/IGC.0b013e3181a83ed9_bb0010","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/S0093-7754(03)00100-3","article-title":"The follow-up of ovarian cancer","volume":"30","author":"Vaidya","year":"2003","journal-title":"Semin Oncol."},{"key":"10.1111\/IGC.0b013e3181a83ed9_bb0015","first-page":"10","article-title":"Cancer statistics. 2005","volume":"55","author":"Jemal","year":"2005","journal-title":"CA Cancer J Clin."},{"key":"10.1111\/IGC.0b013e3181a83ed9_bb0020","doi-asserted-by":"crossref","first-page":"7714","DOI":"10.1016\/S0021-9258(18)32238-5","article-title":"Purification and characterization of a cell-aggregating factor (clusterin), the major glycoprotein in ram testis fluid","volume":"258","author":"Blaschuk","year":"1983","journal-title":"J Biol Chem."},{"key":"10.1111\/IGC.0b013e3181a83ed9_bb0025","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1016\/S1357-2725(02)00041-9","article-title":"Clusterin\/apolipoprotein J in human aging and cancer","volume":"34","author":"Trougakos","year":"2002","journal-title":"Int J Biochem Cell Biol."},{"key":"10.1111\/IGC.0b013e3181a83ed9_bb0030","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1038\/sj.cdd.4401779","article-title":"Challenge and promise: roles for clusterin in pathogenesis, progression and therapy of cancer","volume":"13","author":"Shannan","year":"2006","journal-title":"Cell Death Differ."},{"key":"10.1111\/IGC.0b013e3181a83ed9_bb0035","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/S0002-9440(10)64552-X","article-title":"Overexpression of clusterin in human breast carcinoma","volume":"157","author":"Redondo","year":"2000","journal-title":"Am J Pathol."},{"key":"10.1111\/IGC.0b013e3181a83ed9_bb0040","first-page":"1707","article-title":"Intracellular levels of SGP-2 (clusterin) correlate with tumor grade in prostate cancer","volume":"3","author":"Steinberg","year":"1997","journal-title":"Clin Cancer Res."},{"key":"10.1111\/IGC.0b013e3181a83ed9_bb0045","doi-asserted-by":"crossref","first-page":"9289","DOI":"10.1038\/sj.onc.1208100","article-title":"Isolation and characterization of a novel gene CLUAP1 whose expression is frequently upregulated in colon cancer","volume":"23","author":"Takahashi","year":"2004","journal-title":"Oncogene."},{"key":"10.1111\/IGC.0b013e3181a83ed9_bb0050","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1016\/j.humpath.2004.07.021","article-title":"Overexpression of clusterin in human hepatocellular carcinoma","volume":"35","author":"Kang","year":"2004","journal-title":"Hum Pathol."},{"key":"10.1111\/IGC.0b013e3181a83ed9_bb0055","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.ygyno.2007.11.026","article-title":"Clusterin expression predicts survival of invasive cervical cancer patients treated with radical hysterectomy and systematic lymphadenectomy","volume":"108","author":"Watari","year":"2008","journal-title":"Gynecol Oncol."},{"key":"10.1111\/IGC.0b013e3181a83ed9_bb0060","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1002\/cncr.20765","article-title":"Up-regulated expression of cytoplasmic clusterin in human ovarian carcinoma","volume":"103","author":"Xie","year":"2005","journal-title":"Cancer."},{"key":"10.1111\/IGC.0b013e3181a83ed9_bb0065","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1016\/S0022-5347(01)69130-4","article-title":"Over expression of clusterin is an independent prognostic factor for nonpapillary renal cell carcinoma","volume":"167","author":"Miyake","year":"2002","journal-title":"J Urol."},{"key":"10.1111\/IGC.0b013e3181a83ed9_bb0070","first-page":"3276","article-title":"Enhanced radiosensitivity in prostate cancer by inhibition of the cell survival protein clusterin","volume":"8","author":"Zellweger","year":"2002","journal-title":"Clin Cancer Res."},{"key":"10.1111\/IGC.0b013e3181a83ed9_bb0075","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1016\/j.ijrobp.2005.07.956","article-title":"Clusterin as a therapeutic target for radiation sensitization in a lung cancer model","volume":"63","author":"Cao","year":"2005","journal-title":"Int J Radiat Oncol Biol Phys."},{"key":"10.1111\/IGC.0b013e3181a83ed9_bb0080","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1016\/j.ygyno.2006.06.037","article-title":"Clusterin confers paclitaxel resistance in cervical cancer","volume":"103","author":"Park","year":"2006","journal-title":"Gynecol Oncol."},{"key":"10.1111\/IGC.0b013e3181a83ed9_bb0085","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1038\/sj.neo.7900174","article-title":"Chemosensitization of human renal cell cancer using antisense oligonucleotides targeting the antiapoptotic gene clusterin","volume":"3","author":"Zellweger","year":"2001","journal-title":"Neoplasia."},{"key":"10.1111\/IGC.0b013e3181a83ed9_bb0090","doi-asserted-by":"crossref","first-page":"R86","DOI":"10.1186\/bcr1835","article-title":"Anticlusterin treatment of breast cancer cells increases the sensitivities of chemotherapy and tamoxifen and counteracts the inhibitory action of dexamethasone on chemotherapy-induced cytotoxicity","volume":"9","author":"Redondo","year":"2007","journal-title":"Breast Cancer Res."}],"container-title":["International Journal of Gynecological Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2FIGC.0b013e3181a83ed9","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1048891X24028081?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1048891X24028081?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,23]],"date-time":"2025-07-23T01:17:36Z","timestamp":1753233456000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1048891X24028081"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,11]]},"references-count":18,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2009,11]]}},"alternative-id":["S1048891X24028081"],"URL":"https:\/\/doi.org\/10.1111\/igc.0b013e3181a83ed9","relation":{},"ISSN":["1048-891X"],"issn-type":[{"value":"1048-891X","type":"print"}],"subject":[],"published":{"date-parts":[[2009,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Overexpression of Clusterin in Ovarian Cancer is Correlated With Impaired Survival","name":"articletitle","label":"Article Title"},{"value":"International Journal of Gynecological Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1111\/IGC.0b013e3181a83ed9","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2009 by IGCS and ESGO","name":"copyright","label":"Copyright"}]}}